Variable | Compared groups | MD | SE | p-value | 95% CI |
---|---|---|---|---|---|
PMS-A | Control- Resistive exercise group | 2.60 | 0.64 | 0.000* | 1.30-3.89 |
Control - WBV group | 2.22 | 0.64 | 0.001* | -3.89- - 1.30 | |
Resistive exercise group- WBV group | -0.37 | 0.64 | 0.56 | -1.66-0.91 | |
PMS-C | Control - Resistive exercise group | 2.62 | 0.46 | 0.000* | 1.50-3.74 |
Control - WBV group | 3.02 | 0.46 | 0.000* | 1.90-4.14 | |
Resistive exercise group- WBV group | 0.40 | 0.46 | 0.66 | -0.71-1.51 | |
PMS-D | Control-Resistive exercise group | 2.15 | 0.58 | 0.001* | 0.71-3.58 |
Control - WBV group | 1.80 | 0.58 | 0.009* | 0.36-3.23 | |
Resistive exercise group - WBV group | -0.35 | 0.58 | 1 | -1.78-1.08 | |
PMS-H | Control - Resistive exercise group | 2.02 | 0.58 | 0.003* | 0.57-3.47 |
Control - WBV group | 2.90 | 0.58 | 0.000* | 1.44-4.35 | |
Resistive exercise group- WBV group | 0.87 | 0.58 | 0.42 | -0.57-2.32 | |
Other symptoms | Control - Resistive exercise group | 3.05 | 0.57 | 0.000* | 1.62-4.47 |
Control - WBV group | 2.72 | 0.57 | 0.000* | 1.30-4.14 | |
Resistive exercise group - WBV group | -0.32 | 0.57 | 1 | -1.74- 1.09 | |
Cramp | Control - Resistive exercise group | 0.67 | 0.14 | 0.000* | 0.32-1.03 |
Control - WBV group | 0.37 | 0.14 | 0.03* | 0.02-0.73 | |
Resistive exercise group - WBV group | -0.30 | 0.14 | 0.12 | -0.65- 0.05 | |
Backache | Control - ES group | 0.67 | 0.11 | 0.000* | 0.40-0.94 |
Control - WBV group | 0.57 | 0.11 | 0.000* | 0.30-0.84 | |
ES - WBV group | -0.10 | 0.11 | 0.64 | -0.37- 0.17 |